Attached files

file filename
EX-10.3 - ESCROW AGREEMENT, DATED SEPTEMBER 2, 2020, BY AND AMONG THE REGISTRANT, CONTINEN - Tango Therapeutics, Inc.ea126613ex10-3_bctgacq.htm
EX-99.1 - PRESS RELEASE DATED SEPTEMBER 9, 2020 - Tango Therapeutics, Inc.ea126613e99-1_bctgacq.htm
EX-10.7 - INDEMNITY AGREEMENTS, EACH DATED SEPTEMBER 2, 2020, BY AND BETWEEN THE REGISTRAN - Tango Therapeutics, Inc.ea126613ex10-7_bctgacq.htm
EX-10.5 - SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 2, 2020, BY AND BETWEEN THE REGISTRANT A - Tango Therapeutics, Inc.ea126613ex10-5_bctgacq.htm
EX-10.4 - REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 2, 2020, BY AND AMONG THE REGISTR - Tango Therapeutics, Inc.ea126613ex10-4_bctgacq.htm
EX-10.2 - INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED SEPTEMBER 2, 2020, BY AND BETWEEN T - Tango Therapeutics, Inc.ea126613ex10-2_bctgacq.htm
EX-10.1 - LETTER AGREEMENT, DATED SEPTEMBER 2, 2020, BY AND AMONG THE REGISTRANT AND ITS O - Tango Therapeutics, Inc.ea126613ex10-1_bctgacq.htm
EX-3.2 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPANY - Tango Therapeutics, Inc.ea126613ex3-2_bctgacq.htm
EX-1.1 - UNDERWRITING AGREEMENT, DATED SEPTEMBER 2, 2020, BY AND BETWEEN THE REGISTRANT A - Tango Therapeutics, Inc.ea126613ex1-1_bctgacq.htm
8-K - CURRENT REPORT - Tango Therapeutics, Inc.ea126613-8k_bctgacq.htm

Exhibit 10.6

 

BCTG ACQUISITION CORP.

11682 El Camino Real, Suite 320

San Diego, CA 92130

 

September 2, 2020

 

Boxer Capital, LLC
11682 El Camino Real, Suite 320

San Diego, CA 92130

 

Ladies and Gentlemen:

 

This letter will confirm our agreement that, commencing on the effective date (the “Effective Date”) of the registration statement (the “Registration Statement”) for the initial public offering (the “IPO”) of the securities of BCTG Acquisition Corp. (the “Company”) and continuing until the earlier of (i) the consummation by the Company of an initial business combination or (ii) the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”), Boxer Capital, LLC (“Boxer Capital”) shall make available to the Company certain office space, secretarial and administrative services as may be required by the Company from time to time, situated at 11682 El Camino Real, Suite 320, San Diego, CA 92130 (or any successor location). In exchange therefore, the Company shall pay Boxer Capital a sum not to exceed $10,000 per month, respectively, on the Effective Date and continuing monthly thereafter until the Termination Date. Boxer Capital hereby agrees that it does not have any right, title, interest or claim of any kind in or to any monies that may be set aside in a trust account (the “Trust Account”) that may be established by the Company for the benefit of the Company’s public stockholders upon the consummation of the IPO as described in the Registration Statement (“Claim”) and hereby waives any Claim it may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with the Company and will not seek recourse against the Trust Account for any reason whatsoever.

 

[signature page follows]

 

 

 

 

  Very truly yours,
   
  BCTG ACQUISITION CORP.
     
  By: /s/ Aaron I. Davis
  Name:   Aaron I. Davis
  Title: Chief Executive Officer

 

AGREED TO AND ACCEPTED BY:  
   
BOXER CAPITAL, LLC  
   
By: /s/ Andrew Ellis  
Name:   Andrew Ellis  
Title: Manager